Ethema Health Corporation (GRST)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.07 Million USD | -89.72% |
| 2022 | 489.11 Thousand USD | 81.47% |
| 2021 | 2105.00 USD | 1887.49% |
| 2020 | -42.06 Thousand USD | 98.92% |
| 2019 | -10.32 Million USD | -42.54% |
| 2018 | -2.6 Million USD | 53.4% |
| 2017 | -6.93 Million USD | -539.56% |
| 2016 | -873.95 Thousand USD | -27.21% |
| 2015 | -975.38 Thousand USD | 45.33% |
| 2014 | -1.25 Million USD | -19.73% |
| 2013 | -2.58 Million USD | -0.41% |
| 2012 | -1.04 Million USD | 62.76% |
| 2011 | -2.36 Million USD | -846.32% |
| 2010 | -415.77 Thousand USD | -647.47% |
| 2009 | -39.71 Thousand USD | -177.97% |
| 2008 | -14.28 Thousand USD | 83.85% |
| 2007 | -88.5 Thousand USD | -637.5% |
| 2006 | -12 Thousand USD | -20.55% |
| 2005 | -9954.00 USD | 83.83% |
| 2004 | -61.54 Thousand USD | 26.65% |
| 2003 | -83.9 Thousand USD | 0.0% |
| 2001 | -5.78 Million USD | -282.33% |
| 2000 | 3.17 Million USD | 20.08% |
| 1999 | 2.64 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -157.59 Thousand USD | -64.9% |
| 2024 Q1 | -110.18 Thousand USD | 83.08% |
| 2023 Q2 | 114.51 Thousand USD | -59.64% |
| 2023 Q1 | 283.72 Thousand USD | -10.55% |
| 2023 FY | - USD | -89.72% |
| 2023 Q4 | -564.42 Thousand USD | -430.36% |
| 2023 Q3 | 170.84 Thousand USD | 49.19% |
| 2022 Q3 | 456.43 Thousand USD | 81.0% |
| 2022 FY | - USD | 81.47% |
| 2022 Q4 | 317.18 Thousand USD | -30.51% |
| 2022 Q2 | 252.18 Thousand USD | -9.94% |
| 2022 Q1 | 280.02 Thousand USD | 13.8% |
| 2021 Q1 | 70.9 Thousand USD | 3336.84% |
| 2021 Q4 | 246.06 Thousand USD | -26.11% |
| 2021 FY | - USD | 1887.49% |
| 2021 Q3 | 333 Thousand USD | 237.55% |
| 2021 Q2 | 98.65 Thousand USD | 39.14% |
| 2020 FY | - USD | 98.92% |
| 2020 Q4 | 2063.00 USD | -54.8% |
| 2020 Q3 | 4564.00 USD | -66.0% |
| 2020 Q2 | 13.42 Thousand USD | 122.26% |
| 2020 Q1 | -60.3 Thousand USD | -260.36% |
| 2019 Q1 | -1.3 Million USD | -74.14% |
| 2019 Q4 | 37.6 Thousand USD | 103.88% |
| 2019 FY | - USD | -42.54% |
| 2019 Q2 | -1.48 Million USD | -13.72% |
| 2019 Q3 | -968.4 Thousand USD | 34.67% |
| 2018 Q3 | -848.03 Thousand USD | -28.35% |
| 2018 Q1 | -350.08 Thousand USD | 93.78% |
| 2018 Q2 | -660.73 Thousand USD | -88.74% |
| 2018 Q4 | -748.43 Thousand USD | 11.74% |
| 2018 FY | - USD | 53.4% |
| 2017 Q4 | -5.62 Million USD | -2035.79% |
| 2017 FY | - USD | -539.56% |
| 2017 Q3 | 290.71 Thousand USD | -77.56% |
| 2017 Q2 | 1.29 Million USD | 183.41% |
| 2017 Q1 | -1.55 Million USD | -11.44% |
| 2016 Q2 | 136.09 Thousand USD | -16.59% |
| 2016 FY | - USD | -27.21% |
| 2016 Q4 | -1.39 Million USD | -696.17% |
| 2016 Q1 | 163.16 Thousand USD | 122.21% |
| 2016 Q3 | 233.84 Thousand USD | 71.82% |
| 2015 FY | - USD | 45.33% |
| 2015 Q2 | 145.04 Thousand USD | 151.23% |
| 2015 Q3 | 184.94 Thousand USD | 27.51% |
| 2015 Q4 | -734.51 Thousand USD | -497.15% |
| 2015 Q1 | -283.09 Thousand USD | 76.86% |
| 2014 Q2 | 136.05 Thousand USD | 124.42% |
| 2014 FY | - USD | -19.73% |
| 2014 Q4 | -1.22 Million USD | -640.38% |
| 2014 Q3 | 226.43 Thousand USD | 66.43% |
| 2014 Q1 | -557.12 Thousand USD | 8.67% |
| 2013 Q4 | -610.03 Thousand USD | -800.59% |
| 2013 Q3 | 87.07 Thousand USD | 128.54% |
| 2013 FY | - USD | -0.41% |
| 2013 Q1 | -293.13 Thousand USD | -68.45% |
| 2013 Q2 | -305.06 Thousand USD | -4.07% |
| 2012 Q3 | -351.71 Thousand USD | -14.03% |
| 2012 FY | - USD | 62.76% |
| 2012 Q4 | -174.02 Thousand USD | 50.52% |
| 2012 Q1 | 475.94 Thousand USD | 152.44% |
| 2012 Q2 | -308.43 Thousand USD | -164.81% |
| 2011 Q2 | -695.78 Thousand USD | -234.72% |
| 2011 Q4 | -907.67 Thousand USD | -16.82% |
| 2011 Q3 | -776.97 Thousand USD | -11.67% |
| 2011 Q1 | -207.86 Thousand USD | -20.78% |
| 2011 FY | - USD | -846.32% |
| 2010 FY | - USD | -647.47% |
| 2010 Q4 | -172.1 Thousand USD | -190.58% |
| 2010 Q3 | -59.22 Thousand USD | 46.61% |
| 2010 Q2 | -110.92 Thousand USD | -1794.57% |
| 2010 Q1 | -5855.00 USD | 65.18% |
| 2009 Q3 | -13.77 Thousand USD | -109.34% |
| 2009 Q4 | -16.81 Thousand USD | -22.04% |
| 2009 Q1 | -2542.00 USD | 67.09% |
| 2009 FY | - USD | -177.97% |
| 2009 Q2 | -6582.00 USD | -158.93% |
| 2008 Q1 | -10 Thousand USD | -106.9% |
| 2008 Q3 | -22.52 Thousand USD | 13.34% |
| 2008 Q4 | -7725.00 USD | 65.7% |
| 2008 FY | - USD | 83.85% |
| 2008 Q2 | -25.98 Thousand USD | -159.88% |
| 2007 FY | - USD | -637.5% |
| 2007 Q3 | -15 Thousand USD | 90.32% |
| 2007 Q2 | -155 Thousand USD | -144.09% |
| 2007 Q1 | -63.5 Thousand USD | -6250.0% |
| 2007 Q4 | 145 Thousand USD | 1066.67% |
| 2006 Q2 | -1000.00 USD | 88.89% |
| 2006 Q1 | -9000.00 USD | -800.9% |
| 2006 FY | - USD | -20.55% |
| 2006 Q3 | -1000.00 USD | 0.0% |
| 2006 Q4 | -1000.00 USD | 0.0% |
| 2005 FY | - USD | 83.83% |
| 2005 Q2 | -6722.00 USD | -521.26% |
| 2005 Q3 | -1151.00 USD | 82.88% |
| 2005 Q4 | -999.00 USD | 13.21% |
| 2005 Q1 | -1082.00 USD | 95.32% |
| 2004 Q4 | -23.13 Thousand USD | -164.48% |
| 2004 Q2 | -12.2 Thousand USD | 30.09% |
| 2004 Q3 | -8749.00 USD | 28.3% |
| 2004 Q1 | -17.45 Thousand USD | -256.01% |
| 2004 FY | - USD | 26.65% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | -2000.00 USD | 0.0% |
| 2003 Q1 | -1000.00 USD | 0.0% |
| 2003 Q4 | -4903.00 USD | -145.15% |
| 2001 Q3 | -3.63 Million USD | -985.37% |
| 2001 Q4 | -2.7 Million USD | 25.62% |
| 2001 FY | - USD | -282.33% |
| 2001 Q2 | 410 Thousand USD | 192.86% |
| 2001 Q1 | 140 Thousand USD | -89.06% |
| 2000 FY | - USD | 20.08% |
| 2000 Q2 | 520 Thousand USD | 6.12% |
| 2000 Q3 | 880 Thousand USD | 69.23% |
| 2000 Q4 | 1.28 Million USD | 45.45% |
| 2000 Q1 | 490 Thousand USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.98 Million USD | 118.866% |
| Arem Pacific Corporation | 36.71 Thousand USD | -5543.938% |
| Assisted 4 Living, Inc. | -112.91 Thousand USD | 1935.226% |
| BioCorRx Inc. | -2.68 Million USD | 177.207% |
| Bionik Laboratories Corp. | -4.77 Million USD | 143.39% |
| Banyan Corp. | 583.94 Thousand USD | -254.859% |
| Clearday, Inc. | -7.53 Million USD | 127.496% |
| Dental Patient Care America, Inc. | 12.87 Thousand USD | -15997.04% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | -1.08 Million USD | 290.408% |
| First Choice Healthcare Solutions, Inc. | -2.2 Million USD | 193.772% |
| Selectis Health, Inc. | -7.29 Million USD | 128.408% |
| HealthLynked Corp. | -2.75 Million USD | 175.343% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 178.066% |
| JRSIS Health Care Corporation | 28.84 Thousand USD | -7083.568% |
| Comjoyful International Company | 167.89 Thousand USD | -1134.207% |
| Medical Facilities Corporation | 77.94 Million USD | 97.341% |
| MedSmart Group Inc. | 47.8 Thousand USD | -4234.272% |
| North America Frac Sand, Inc. | -623.33 Thousand USD | 432.436% |
| Nova Leap Health Corp. | 994.46 Thousand USD | -108.371% |
| Nexteligent Holdings, Inc. | -201.73 Thousand USD | 1127.201% |
| PAO Group, Inc. | 292.96 Thousand USD | -607.315% |
| Primemd Inc. | 3.42 Million USD | 39.533% |
| Raffles Medical Group Ltd | 100.7 Million USD | 97.942% |
| Ryman Healthcare Limited | -54.51 Million USD | 103.801% |
| Stem Cell Authority, Ltd. | -4233.00 USD | 49052.799% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -2.89 Million USD | 171.596% |
| Mycotopia Therapies, Inc. | -555.5 Thousand USD | 473.024% |
| U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | 4328.922% |
| Veltex Corporation | -938.45 Thousand USD | 320.806% |
| World Financial Holding Group | -28.43 Thousand USD | 7388.681% |
| Xcelerate Inc. | -2.53 Million USD | 181.635% |